Credit Suisse Ag Guardant Health, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Guardant Health, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 1,844,796 shares of GH stock, worth $57.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,844,796

Previous 1,756,335 5.04%

Holding current value

$57.3 Million

Previous $47.5 Million 19.89%

% of portfolio

0.04%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.13 - $26.91 $1.52 Million - $2.38 Million	88,461 Added 5.04%	1,844,796 $38.1 Million
Q4 2023 Feb 08, 2024	BUY	$21.58 - $29.5 $859,466 - $1.17 Million	39,827 Added 2.32%	1,756,335 $47.5 Million
Q3 2023 Nov 13, 2023	SELL	$25.8 - $39.97 $12.3 Million - $19 Million	-475,213 Reduced 21.68%	1,716,508 $50.9 Million
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $918,219 - $1.67 Million	43,850 Added 2.04%	2,191,721 $78.5 Million
Q1 2023 May 10, 2023	BUY	$22.92 - $33.76 $844,097 - $1.24 Million	36,828 Added 1.74%	2,147,871 $50.3 Million
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $7.68 Million - $18 Million	301,890 Added 16.69%	2,111,043 $57.4 Million
Q3 2022 Nov 10, 2022	SELL	$43.66 - $61.0 $27,287 - $38,125	-625 Reduced 0.03%	1,809,153 $97.4 Million
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $235,315 - $631,562	-8,165 Reduced 0.45%	1,809,778 $73 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $382,236 - $796,081	7,922 Added 0.44%	1,817,943 $120 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.77 Million - $2.4 Million	19,946 Added 1.11%	1,810,021 $181 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $426,390 - $570,577	4,317 Added 0.24%	1,790,075 $224 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $3.55 Million - $5.35 Million	32,313 Added 1.84%	1,785,758 $222 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $14.4 Million - $20.3 Million	113,127 Added 6.9%	1,753,445 $268 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $15.7 Million - $21.3 Million	157,003 Added 10.58%	1,640,318 $211 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $6.66 Million - $9.27 Million	82,954 Added 5.92%	1,483,315 $166 Million
Q2 2020 Aug 12, 2020	BUY	$60.49 - $97.5 $33.2 Million - $53.6 Million	549,597 Added 64.6%	1,400,361 $114 Million
Q1 2020 May 13, 2020	BUY	$59.04 - $88.81 $5.71 Million - $8.59 Million	96,710 Added 12.83%	850,764 $59.2 Million
Q4 2019 Feb 12, 2020	BUY	$59.49 - $82.78 $10.6 Million - $14.8 Million	178,873 Added 31.1%	754,054 $58.9 Million
Q3 2019 Nov 12, 2019	BUY	$62.59 - $110.3 $3.69 Million - $6.5 Million	58,945 Added 11.42%	575,181 $36.7 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $5.26 Million - $7.49 Million	82,197 Added 18.94%	516,236 $44.6 Million
Q1 2019 May 14, 2019	SELL	$34.3 - $97.98 $288,668 - $824,599	-8,416 Reduced 1.9%	434,039 $33.3 Million
Q4 2018 Feb 13, 2019	BUY	$29.2 - $46.1 $12.9 Million - $20.4 Million	442,455 New	442,455 $16.6 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.17B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account